Back to Search
TODD MARTINO, PHARMD./RPH.
PHARMD./RPH.
Pharmacist
NPI: 1447439823Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
048283(NY)
Research & Publications (20)
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.
PMID 19280185·Eur J Nucl Med Mol Imaging·2009
2-rct
Diurnal physiology: core principles with application to the pathogenesis, diagnosis, prevention, and treatment of myocardial hypertrophy and failure.
PMID 19556457·J Appl Physiol (1985)·2009
6-review
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.
PMID 19228174·CNS Neurosci Ther·2009
8-other
DNA instability in replicating Huntington's disease lymphoblasts.
PMID 19210789·BMC Med Genet·2009
8-other
Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?
PMID 19059613·J Neurol Sci·2009
8-other
Diurnal profiling of neuroendocrine genes in murine heart, and shift in proopiomelanocortin gene expression with pressure-overload cardiac hypertrophy.
PMID 18550896·J Mol Endocrinol·2008
7-preclinical
Vascular circadian rhythms in a mouse vascular smooth muscle cell line (Movas-1).
PMID 18768761·Am J Physiol Regul Integr Comp Physiol·2008
7-preclinical
Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters.
PMID 18272659·Am J Physiol Regul Integr Comp Physiol·2008
7-preclinical
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia.
PMID 17682007·J Neurol Neurosurg Psychiatry·2007
5-case
Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body time of day.
PMID 17553849·Am J Physiol Regul Integr Comp Physiol·2007
7-preclinical
Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.
PMID 17440989·Am J Med Genet B Neuropsychiatr Genet·2007
8-other
Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization.
PMID 17339537·Hypertension·2007
7-preclinical
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.
PMID 16221531·Neurosci Lett·2006
4-observational
Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease.
PMID 16184606·Am J Med Genet B Neuropsychiatr Genet·2005
8-other
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblasts.
PMID 15546151·Am J Med Genet B Neuropsychiatr Genet·2005
8-other
Lipid-soluble antioxidants and pregnancy: maternal serum levels of coenzyme Q10, alpha-tocopherol and gamma-tocopherol in preeclampsia and normal pregnancy.
PMID 14988604·Gynecol Obstet Invest·2004
8-other
Day/night rhythms in gene expression of the normal murine heart.
PMID 14985853·J Mol Med (Berl)·2004
7-preclinical
Italian Huntington disease patients--data and tissue bank.
PMID 14598094·Neurol Sci·2003
4-observational
Dissecting mechanisms of innate and acquired immunity in myocarditis.
PMID 12826817·Curr Opin Cardiol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 NIAGARA ST
TONAWANDA, NY 14150 - Phone
- (716) 693-6400
Quick Facts
- NPI
- 1447439823
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile